Sort by: after hours % change | delayed % change | gain open | gain high | gain close | publishing date
approved crawled time : 22:01 save search
Malaysia’s Ho Wah Genting Berhad Advises Guardion Health Sciences That It Has received Regulatory Product Registration Approval for Second Immune Support Dietary Supplement Designed and Produced by Guardion Health Sciences
Published: 2021-01-28 (Crawled : 22:01) - globenewswire.com
GHSI | $7.99 -0.75% -0.75% 5.6K
|
Health Services
|
| O: -6.25%
H: 11.79%
C: -1.98%
approval designation
Myovant Sciences Announces FDA Approval of ORGOVYX™ (relugolix), the First and Only Oral Gonadotropin-Releasing Hormone (GnRH) Receptor Antagonist for Advanced Prostate Cancer
Published: 2020-12-18 (Crawled : 22:01) - globenewswire.com
MYOV | $26.98 -0.04% 0.0% 0
|
Health Technology
| Email alert
Add to watchlist
prostate cancer approval fda fda approval cancer hormone
FDA Approves Amgen's RIABNI™ (rituximab-arrx), A Biosimilar To Rituxan® (rituximab)
Published: 2020-12-17 (Crawled : 22:01) - biospace.com/
AMGN | $269.03 2.39% 2.33% 3.4M
|
Health Technology
|
| O: 0.3%
H: 0.99%
C: 0.93%
fda approval fda approval biosimilar
Winnebago Industries Board of Directors Approves Quarterly Cash Dividend of $0.12 Per Share
Published: 2020-12-16 (Crawled : 22:01) - globenewswire.com
WGO | $62.54 2.06% -0.01% 500K
|
Consumer Durables
|
| O: 1.24%
H: 1.17%
C: -0.17%
approval
MacroGenics Announces FDA Approval of MARGENZA™ for Patients with Pretreated Metastatic HER2-Positive Breast Cancer
Published: 2020-12-16 (Crawled : 22:01) - globenewswire.com
MGNX | $15.62 -2.8% -2.88% 1M
|
Health Technology
|
| O: 11.44%
H: 2.33%
C: -10.52%
fda approval fda approval cancer breast cancer positive her2+ her2- her2
State of Florida approves option agreement with Alico to acquire approximately 5,804 acres of Alico Ranch
Published: 2020-12-15 (Crawled : 22:01) - globenewswire.com
ALCO | $27.99 4.21% 4.04% 22K
|
Process Industries
|
| O: 0.7%
H: 2.92%
C: 0.76%
approval
Albireo Submits for U.S. FDA and EMA Product Approval of Once-Daily Odevixibat for PFIC
Published: 2020-12-08 (Crawled : 22:01) - globenewswire.com
ALBO | $44.15 -0.23% 0.39% 1.2M
|
Health Technology
|
| O: 0.68%
H: 0.83%
C: -3.47%
fda approval ema